Sverre Erik Kjeldsen

Professor Emeritus

University of Oslo

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Emeritus Sverre Erik Kjeldsen is affiliated with the University of Oslo, Norway. His research primarily focuses on hypertension management, blood pressure targeting, and cardiovascular outcomes, as evidenced by his recent articles discussing the 2024 European Society of Cardiology Guidelines and findings from the VALUE Trial. He is recognized for his contributions to the field, particularly in the implications of blood pressure treatment in various patient populations.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (3)

Mattias Brunström

Umeå Universitet Medicinska fakulteten

SWEDEN

View details

Krzysztof Narkiewicz

Medical University of Gdansk

POLAND

View details

Giuseppe Mancia

University of Milano-Bicocca

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sverre Erik Kjeldsen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Management of ‘Elevated’ blood pressure according to the 2024 European Society of Cardiology Guidelines: lack of supportive evidence and high risk of excessive treatment

Non-debatable issues in defining blood pressure targets for hypertension – Editorial

In Memoriam: Stevo Julius, MD, ScD

Insights from the VALUE Trial: Achieving blood pressure targets for renal protection

Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial

Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?

Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study

Orthostatic hypertension: the forgotten phenotype

Should treatment of ‘elevated’ blood pressure, especially in older people, be based on global risk estimation?

Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial

Collaborators (3)

Mattias Brunström

Krzysztof Narkiewicz

Giuseppe Mancia

Make your next move.